BG
SGMO

Bellevue Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bellevue Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,850,000
Closed -$36.4M – 226
2020
Q3 		$36.4M Hold
3,850,000
– – 0.5% 57
2020
Q2 		$34.5M Hold
3,850,000
– – 0.49% 52
2020
Q1 		$24.5M Hold
3,850,000
– – 0.48% 57
2019
Q4 		$32.2M Buy
3,850,000
+200,000
+5% +$1.84M 0.51% 49
2019
Q3 		$33M Hold
3,650,000
– – 0.61% 43
2019
Q2 		$39.3M Buy
+3,650,000
New +$38.8M 0.67% 38

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return